Manufacturing news briefs – stories you might have missed

AnteoTech asked for further information for Covid-19 test application Surface chemical company AnteoTech has been asked by Australia’s Therapeutic Goods Administration to supply further information on its EuGeni test reader and SARS CoV-2 Rapid Diagnostic Test (RDT). The company is one of three Australian manufacturers of RDT tests awaiting approval to sell their tests locally.…

Manufacturing news briefs – stories you might have missed

LGP to enter psychedelics market Cannabis producer Little Green Pharma has been granted a Schedule 9 licence by the Western Australian Department of Health to supply the psychedelic psilocybin to treat mental illness. LGB has established a special purpose subsidiary for psychedelic business which is planning to manufacture psilocybin in WA and conduct clinical trials.…

Manufacturing news briefs – stories you might have missed

AnteoTech signs SEA distributor for EuGeni Nanotechnology company AnteoTech has appointed South East Asian distributors for the Brisbane company’s EuGeni SARS-CoV-2 antigen rapid diagnostic test (pictured). Biomed Global Sdn. Bhd will distribute the EuGeni reader platform and rapid tests in Malaysia. Singapore, Indonesia, Vietnam, Thailand and Myanmar. AnteoTech specialises in surface chemistry, and has core…